Photocure ASA (OSL:PHO)
68.60
-0.40 (-0.58%)
At close: Dec 23, 2025
Photocure ASA Market Cap
Photocure ASA has a market cap or net worth of 1.83 billion as of December 24, 2025. Its market cap has increased by 24.01% in one year.
Market Cap
1.83B
Enterprise Value
1.59B
Revenue
537.59M
Ranking
n/a
PE Ratio
861.76
Stock Price
68.60
Market Cap Chart
Since March 7, 2000, Photocure ASA's market cap has decreased from 2.71B to 1.83B, a decrease of -32.77%. That is a compound annual growth rate of -1.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 1.83B | 8.61% |
| Dec 30, 2024 | 1.68B | -8.01% |
| Dec 29, 2023 | 1.83B | -36.89% |
| Dec 30, 2022 | 2.89B | 4.55% |
| Dec 30, 2021 | 2.77B | -2.73% |
| Dec 30, 2020 | 2.85B | 46.02% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.81B |
| Nordhealth AS | 2.94B |
| Thor Medical ASA | 1.71B |
| ArcticZymes Technologies ASA | 1.12B |
| Omda AS | 980.27M |
| Vistin Pharma ASA | 904.63M |
| Gentian Diagnostics ASA | 863.65M |
| Nykode Therapeutics AS | 751.06M |